ISRCTN69985145已完成未知
Treatment of hidradenitis suppurativa evaluation study (THESEUS)
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 151
研究概览
简要总结
2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35450918/ (added 25/04/2022) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37823414/ (added 16/10/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/38149635/ (added 28/12/2023)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Adults at least 18 years old with active HS of any severity
- •2. Diagnosis confirmed by recruiting clinician with experience of HS care
- •3. HS not adequately controlled by current treatment
- •4. At least one of the five study interventions is appropriate for participant’s care
排除标准
- •1. Unable or unwilling to give informed consent
- •2. Pregnancy or breastfeeding
研究者
相似试验
已完成
2 期
A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa.Hidradenitis SuppurativaNCT03248531UCB Biopharma SRL90
已完成
不适用
Treatment of Hidradenitis Suppurativa With Eth 755nm Alexandrite LaserHidradenitis SuppurativaNCT03054155Wayne State University30
已完成
不适用
Therapeutic Effect of Methalazine on 27 Cases of Suppurative HidradenitisHidradenitis SuppurativaNCT06568224The First Affiliated Hospital with Nanjing Medical University27
进行中（未招募）
2 期
A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic TherapyHidradenitis SuppurativaNCT05139602AbbVie210
已完成
2 期
Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis SuppurativaHidradenitis SuppurativaNCT05819398Boehringer Ingelheim209